e000568.full.pdf (676.06 kB)
Download file

Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)

Download (676.06 kB)
journal contribution
posted on 25.03.2022, 15:58 authored by Philip O'Gorman, Suzanne Norris
COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored.

History

Comments

The original article is available at https://bmjopengastro.bmj.com/

Published Citation

O'Gorman P, Norris S. Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterol. 2021;8(1):e000568.

Publication Date

24 June 2021

PubMed ID

34168043

Department/Unit

  • School of Physiotherapy

Publisher

BMJ Publishing Group Ltd & British Society of Gastroenterology

Version

  • Published Version (Version of Record)